Home | Medical-Newswire.Com:
(Medical-NewsWire.com, January 11, 2018 ) End Stage renal disease (ESRD) occurs when the kidneys are no longer able to carry out their daily functions, requiring either dialysis or transplantation to sustain life. When properly functioning, kidneys act to filter the body of metabolic wastes, which are excreted as urine, and to maintain fluid balance. Chronic kidney failure, a decline in kidney function most often related to diabetes or hypertension, but resulting from other causes as well, including vascular disease, genetic disorders, and exposure to toxic levels of certain drugs. The best strategy for preventing ESRD is to detect chronic kidney failure at the earliest possible stage so that the decline in kidney function can be slowed through the use of medications and tight control of blood sugar and blood pressure levels.
The global ESRD market increased at a significant CAGR during the span of 5 years, i.e. 2010-2015 and projections are made that the market would rise in the next five years i.e. 2016-2020 tremendously. The upsurge in the market was due to the various reasons such as is diabetic nephropathy, genetic diseases, infection, drugs, traumatic injury, major surgery and etc. The market can be segmented on the basis of treatment as kidney transplant and dialysis. The global dialysis market can be segmented on the basis of products and services. On the basis of products, the market is segmented into hemodialysis and peritoneal dialysis while on the basis of services, the market is segmented into in-center dialysis and home dialysis.
The growth drivers for the market are: rise in diabetic and aging population, upsurge in per capita healthcare expenditure along with the emerging countries such as India, China and Brazil. Despite the market is governed by various growth drivers, there are certain challenges faced by the market such as: disparities in the access to renal transplant therapy, less public awareness and negative societal effects.
For more information about this report: http://www.reportsweb.com/global-end-stage-renal-disease-esrd-market-size-trends-and-forecasts-2016-2020
The report titled "Global End Stage Renal Disease (ESRD) Market: Size, Trends and Forecasts (2016-2020)" provides an in-depth analysis of the global ESRD market with detailed analysis of market size and growth, market share and economic impact of the industry. The report also provides market size of each of the segments of the market on the basis of the treatment opted by the patients along with the detailed overview of the home dialysis market. The report provides detailed market share analysis of the global dialysis market by players as well.
The report also includes the country analysis of the U.S. and Japan for ESRD market. It provides the analysis of ESRD patient volume along with the kidney transplant and dialysis market on the basis of the volume. The segments of the dialysis market are also analyzed in detail.
The report provides detailed regional analysis of North America, Europe, Meddle East and Africa (EMEA), Asia-Pacific and Latin America for the dialysis market. Regional analysis includes market size by volume along with the segments and clinic operators in each region.
Furthermore, the report assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global ESRD market has also been forecasted for the period 2016-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. The competition in the global dialysis market is stiff and dominated by the big players like FMC. Further, key players of the dialysis market Baxter and Davita are also profiled with their financial information and respective business strategies.
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001274179/sample
- North America
- Latin America
- The U.S.
- Fresenius Medical Care
- Baxter International
- Davita Healthcare Partners
1 Fresenius Medical Care AG & Co. KGaA
1.1 Business Overview
1.2 Financial Overview
1.3 Business Strategy
2. Baxter International, Inc.
2.1 Business Overview
2.2 Financial Overview
2.3 Business Strategy
3 Davita Healthcare Partners Inc.
3.1 Business Overview
3.2 Financial Overview
3.3 Business Strategy
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001274179/buying